Is the case reviewable?
Which diagnosis, biomarker, pathology and prior-treatment records are required?
ADVANCED CANCER CARE PLANNING
Start with records, physician eligibility review, an itemized estimate and a safe travel plan—not a promise of treatment or outcome.

FIRST PRINCIPLE
CAR-T is a complex, personalized cellular therapy. A licensed specialist must determine whether a particular product or clinical pathway may be appropriate after reviewing the exact diagnosis, prior treatments, pathology, imaging, current condition and other risks.
The National Cancer Institute explains that CAR-T modifies a patient's T cells to recognize cancer, while the FDA highlights potentially serious or life-threatening risks. Patients should maintain contact with their current oncology team and should not delay urgent local care while exploring an overseas opinion.
BEFORE TRAVEL
Which diagnosis, biomarker, pathology and prior-treatment records are required?
Is this an approved product, an investigator-led study or another clinical pathway?
Request an itemized estimate for evaluation, cell collection, manufacturing, conditioning, infusion, monitoring, medicines and possible intensive care.
Confirm testing, manufacturing time, inpatient monitoring, caregiver expectations and fitness-to-fly review.
Clarify emergency contacts, English records, home-oncologist communication and required follow-up.
RECORD CHECKLIST
Do not send full records through a public post or direct message. Use the initial form only to request coordination; sensitive files should be shared only through an agreed secure process.
HOW GLOBAL HEALTH PILOT HELPS
We clarify the request and identify information gaps.
We organize documents, translation needs and questions for a licensed provider.
With authorization, we can help request physician-led review, availability and an itemized estimate. A response is not guaranteed.
If a provider accepts the case, we can coordinate interpretation, appointments and non-clinical logistics around its instructions.
CONFIDENTIAL FIRST STEP
The initial review does not determine eligibility, recommend treatment or replace the patient's oncology team.
This guide is general planning information, not medical advice, diagnosis, treatment recommendation or a guarantee that a hospital will accept a case.